Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot TrialHarald Prüß, Jan M. Schwab, Oliver Wengert et al.|PLoS ONE|2013Cited by 107